In a patient with known chronic kidney disease and a baseline serum creatinine of 360 µmol/L, the admission creatinine rises to 380 µmol/L; how should this change be classified and what AKI stage, if any, does it represent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

AKI Stage 1 on CKD

This represents AKI Stage 1 superimposed on chronic kidney disease (acute-on-chronic kidney injury). The creatinine rise from 360 to 380 µmol/L is a 5.6% increase, which does not meet KDIGO criteria for AKI, but this percentage-based approach significantly underestimates acute injury in patients with pre-existing CKD 1.

Why This is AKI Despite Not Meeting KDIGO Percentage Criteria

The KDIGO definition requires either:

  • A rise ≥26 µmol/l (0.3 mg/dl) within 48 hours, OR
  • A 50-99% rise from baseline within 7 days for Stage 1 1

Your patient has a 20 µmol/L rise, which falls just short of the absolute 26 µmol/L threshold. However, percentage-based creatinine changes are fundamentally flawed in CKD patients because the same degree of kidney function loss produces much smaller percentage increases when baseline creatinine is already elevated 2, 3.

The Mathematical Problem with Percentage Changes in CKD

Mathematical modeling demonstrates that after a 90% reduction in kidney function:

  • Normal baseline kidney function: 246% creatinine rise
  • Stage 3 CKD: only 92% rise
  • Stage 4 CKD: only 47% rise 2

The absolute increase remains nearly identical (1.8-2.0 mg/dl) across all baseline kidney function levels, but percentage changes become progressively smaller with worse baseline function 2.

Alternative Criteria Support AKI Diagnosis

The reference change value (RCV) criterion defines acute-on-chronic kidney injury as ≥25% increase in creatinine within 7 days 4. Your patient's 5.6% rise doesn't meet this either, but this highlights the clinical dilemma.

In real-world practice, a 20 µmol/L rise in a CKD patient with acute illness should raise concern for early AKI, even if it doesn't formally meet diagnostic thresholds. The creatinine kinetics model suggests that absolute changes over 24-48 hours are more reliable than percentages in CKD patients 2, 3.

Clinical Approach

Monitor closely for:

  • Further creatinine rises over the next 24-48 hours
  • Urine output (<0.5 ml/kg/h for >6 hours would confirm Stage 1 AKI) 1
  • Additional 6 µmol/L rise would meet the absolute KDIGO threshold

Common pitfall: Dismissing small percentage changes in CKD patients as "stable" when they actually represent significant acute deterioration. A 20 µmol/L rise may seem minor percentage-wise, but represents meaningful kidney function loss 4, 3.

Formal Classification

  • Current status: Does not formally meet KDIGO AKI criteria yet
  • CKD stage: Likely Stage 4 (baseline Cr 360 µmol/L ≈ eGFR 15-29 ml/min)
  • Clinical concern: High risk for progression to formal AKI Stage 1 with continued monitoring 4

If urine output criteria are met (<0.5 ml/kg/h for >6 hours), this would be classified as AKI Stage 1 on CKD regardless of creatinine percentage 1.

References

Research

Creatinine kinetics and the definition of acute kidney injury.

Journal of the American Society of Nephrology : JASN, 2009

Research

Kidney Disease Improving Global Outcomes or creatinine kinetics criteria in acute kidney injury: a proof of concept study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.